Arkolith/Insider Trading/BDTX/Form 4

Behbahani Ali

DirectorBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Jul 6, 2023
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 5, 2023Buy(P)1.0M$5.00$5.0M4.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-041567) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML